FDA Requests Stakeholder Participation in PDUFA Reauthorization Consultation Meetings

Summary

The FDA is seeking public feedback from patient advocacy groups, healthcare professionals, and scientific experts to ensure continuity in the development of the next Prescription Drug User Fee Act (PDUFA) program, which is set to expire in September 2022.